Literature DB >> 25603426

Targeting FOXM1 auto-regulation in cancer.

Andrei L Gartel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25603426      PMCID： PMC4622879          DOI： 10.4161/15384047.2014.987566

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  13 in total

Review 1.  Therapeutic applications of transcription factor decoy oligonucleotides.

Authors:  M J Mann; V J Dzau
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  Thiostrepton, proteasome inhibitors and FOXM1.

Authors:  Andrei L Gartel
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

3.  Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1.

Authors:  Senthil K Radhakrishnan; Uppoor G Bhat; Douglas E Hughes; I-Ching Wang; Robert H Costa; Andrei L Gartel
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

4.  Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.

Authors:  Tanya V Kalin; I-Ching Wang; Timothy J Ackerson; Michael L Major; Carol J Detrisac; Vladimir V Kalinichenko; Alexander Lyubimov; Robert H Costa
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

Review 5.  FOX(M1) news--it is cancer.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

6.  A novel mode of FoxM1 regulation: positive auto-regulatory loop.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  Cell Cycle       Date:  2009-06-09       Impact factor: 4.534

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

8.  SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.

Authors:  Xin-Hua Cheng; Markaisa Black; Vladimir Ustiyan; Tien Le; Logan Fulford; Anusha Sridharan; Mario Medvedovic; Vladimir V Kalinichenko; Jeffrey A Whitsett; Tanya V Kalin
Journal:  PLoS Genet       Date:  2014-09-25       Impact factor: 5.917

9.  The oncogenic transcription factor FOXM1 and anticancer therapy.

Authors:  Andrei L Gartel
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

10.  Thiazole Antibiotics Siomycin a and Thiostrepton Inhibit the Transcriptional Activity of FOXM1.

Authors:  Andrei L Gartel
Journal:  Front Oncol       Date:  2013-06-06       Impact factor: 6.244
View more
  4 in total

1.  FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells.

Authors:  Zuhal Hamurcu; Nesrin Delibaşı; Ufuk Nalbantoglu; Elif Funda Sener; Nursultan Nurdinov; Bayram Tascı; Serpil Taheri; Yusuf Özkul; Hamiyet Donmez-Altuntas; Halit Canatan; Bulent Ozpolat
Journal:  J Mol Med (Berl)       Date:  2019-02-07       Impact factor: 4.599

2.  A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS.

Authors:  Marianna Halasi; Renáta Váraljai; Elizaveta Benevolenskaya; Andrei L Gartel
Journal:  J Biol Chem       Date:  2015-11-11       Impact factor: 5.157

Review 3.  Regulation of the master regulator FOXM1 in cancer.

Authors:  Guo-Bin Liao; Xin-Zhe Li; Shuo Zeng; Cheng Liu; Shi-Ming Yang; Li Yang; Chang-Jiang Hu; Jian-Ying Bai
Journal:  Cell Commun Signal       Date:  2018-09-12       Impact factor: 5.712

4.  Structure-Activity Relationship of N-Phenylthieno[2,3-b]pyridine-2-carboxamide Derivatives Designed as Forkhead Box M1 Inhibitors: The Effect of Electron-Withdrawing and Donating Substituents on the Phenyl Ring.

Authors:  César Sebastian Huerta-García; David J Pérez; Carlos A Velázquez-Martínez; Seyed Amirhossein Tabatabaei Dakhili; Antonio Romo-Mancillas; Rafael Castillo; Alicia Hernández-Campos
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.